Meropenem vs imipenem plus cilastatin for severe infections is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Meropenem vs imipenem plus cilastatin for severe infections
ID - 451820
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451820/all/Meropenem_vs_imipenem_plus_cilastatin_for_severe_infections
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -